Antioxidative potential of vitamin c against chemotherapeutic agent
mitomycin c induced genotoxicity in somatic and germ cells in mouse test model.
The use of laser therapy may also be able to reach the tumor by fibro optics and in conjunction with chemotherapeutic agents
may provide a better prognosis for patients with NPC.
"Recent research conducted by the United States National Cancer Institute and Cornell University demonstrated that administering reovirus in combination with various chemotherapeutic agents
potentiates, or enhances tumour-killing, thus preventing the cancer cells from developing drug resistance," said Dr.
The chemotherapeutic agent
Tamoxifen, used widely in the treatment of breast cancer, also decreases GC production in vinblastine-resistant cells.
Glial tumors can be resistant to chemotherapy from the time the person is diagnosed or can develop resistance from exposure to chemotherapeutic agents
(Prados & Levin, 2000).
Unfortunately, this therapeutic ideal is seldom attained because cancer cells naturally have certain means to resist the action of chemotherapeutic agents
The chemical involved contained nitrogen, and it occurred to Ehrlich that if the similar but much more poisonous element arsenic were substituted for the nitrogen, it might prove a more effective chemotherapeutic agent
For more than four decades, the chemotherapeutic agent
doxorubicin has been used to treat a number of human cancers, including that of the prostate.
The system is designed to deliver chemotherapeutic agent
Melophan to the liver for cancer patients who have liver tumors that cannot be removed.
(Calgary, Canada) has been granted Canadian Patent 2,437,468 entitled "Sensitization of Chemotherapeutic Agent
Resistant Neoplastic Cells with Reovirus." The claims describe using a combination of reovirus and chemotherapy to treat cancer patients, and particularly those who are resistant to or may develop resistance to chemotherapeutic treatments.
An oral form of the chemotherapeutic agent
cladribine (Mylinax), produced by IVAX and Serono, has been tested preliminarily to determine if the oral form can achieve the blood levels obtainable with an intravenous preparation.
Currently, Marc Pharmaceuticals is working on a betulinol-based chemotherapeutic agent
to treat cancer and other life-threatening diseases.